Health

A recent meta-analysis has shown that loneliness and social isolation are risk factors for coronary heart disease and stroke. These latest findings, specific to cardiovascular outcomes, are consistent with substantial research indicating broad health risks (eg, immune functioning, cardiovascular functioning, cognitive decline) associated with the quantity and quality of social relationships—including several meta-analyses documenting mortality risk. In the most comprehensive of these, the overall odds for mortality was 1.50, similar to the risk

We are delighted to present a new collaboration with The Life Rooms, Mersey Care NHS Foundation Trust.     The Life Rooms provides a safe and welcoming space to meet others, access opportunities and learn about community resources. Their fantastic work extends to Walton, Southport, Bootle, South Liverpool Treatment Centre and Playhouse Theatre in Liverpool.  We are pleased to support the community of patients and members of the staff Mersey Care NHS Trust and

Nursing Times magazine features our CEO in an interview about COVID-19 and our 'Resilience, Mind and Rhythm' Online course.  In Collaboration with Noel McDermott. Our Founder and CEO, Sherezade Ruano has been interviewed by Nursing Times in acknowledgement to the positive feedback received by healthcare professionals and NHS staff for our online course – Developing Emotional Resilience: Increase your ability to cope with life’s daily challenges    Nursing Times - MENTAL HEALTH  23 April, 2020 by

Mental Wellbeing for NHS clinical staff: building resilience in times of uncertainty. Understanding the role of healthcare professionals in the world by Sherezade Ruano, Founder and CEO of RhythmiaBreath.   The NHS is one of the largest employers in the world: its 1.3 million staff in England and Wales care for 1 million patients every 36 hours – equivalent to 243 million patients each year.  RhythmiaBreath NHS Wellbeing Programme has been carefully designed to offer support

Atrial fibrillation is the most common cardiac arrhythmia and symptoms overlap with physiological sensations of anxiety. Patients with atrial fibrillation can demonstrate anxiety sensitivity even in the absence of actual atrial fibrillation symptoms. Interoceptive exposure is effective in treating anxiety sensitivity, and recently, mindfulness has been proposed as an enhancement strategy to facilitating inhibitory learning in exposure therapy. This pragmatic study piloted a brief mindfulness and interoceptive exposure treatment for

Article by Health Innovation Network. Gone are the days when clinicians rejected the idea that patients would use technology. Gone are the days when they believed technology could not improve outcomes. And gone are the days when clinicians worried about their job being taken by a robot. Now instead, clinicians are asking when they will get the digital tools they need to improve outcomes, efficiency and patient care. Well, at least this

Author: Dr Alberto Pertusa. Consultant Psychiatrist. Harley Stree. London. Website: https://psychiatristlondon.co.uk People who come to see me in order to seek help for their anxiety often ask whether medication is necessary to alleviate the anxiety that does not seem to have responded to basic interventions such as talking therapy or other interventions like mindfulness or exercise. When anxiety is not accompanied by another mental condition, or very severe (for example, Panic Disorder), I tend to explain

Yoga has finally been proven by scientific research to improve clinical outcomes after myocardial infarction, to decrease symptoms in heart failure and improve quality of life. The following abstract was presented in the last European Society of Cardiology Congress, August 2019, and was chosen the 'Abstract of the day'!   ESC Congress News 2019 - Paris, France 31 Aug 2019 Percutaneous coronary intervention (PCI) is widely used to manage ST-elevated myocardial infarction (STEMI) but the

Clear and convincing clinical evidence has established that living with an implantable cardioverter-defibrillator (ICD) saves patients’ lives. In a 1999 landmark trial comparing the ICD to anti-arrhythmic drugs, the “ICD remains superior in prolonging survival after life-threatening arrhythmia.” Concomitantly, psychosocial research on the ICD has shown that living with the device as a treatment for life-threatening arrhythmias can lead to further/increased anxiety, isolation, hostility, and depression. The typical ICD recipient